Vividion Therapeuticsincis A Clinical Stage Biopharmaceutical Company Based In San Diegospecializing In Covalent Chemoproteomicsfounded In 2013Vividion Focuses On Developing Precision Therapeutics For Challenging Targets In Oncology And Immunologythe Company Operates As A Wholly Owned Subsidiary Of Bayer Agwhile Maintaining Its Independent Operations Vividion Utilizes A Proprietary Platform That Combines Chemoproteomicscovalent Chemistry Librariesand Target Agnostic Screeningthis Innovative Approach Allows The Identification Of Small Molecules That Selectively Interact With Previously Undruggable Targetsthe Companyae S Pipeline Is Dedicated To Addressing Oncology And Immune Disorderswith Multiple Programs Advancing Toward Clinical Developmentvividion Has Also Announced Plans To Expand With A New Global R&D Centerreflecting Its Growth In Discovery And Clinical Programs
No conferences found for this company.
| Company Name | Vividion Therapeutics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
